The present work describes the engineering and characterization of a new Ca 2+ -activated photoprotein (Photina ® ) and its use in mammalian cell lines for implementation of flash luminescence cell-based assays for high-throughput screening (HTS). When used to measure the activation of 2 G protein-coupled receptors (GPCRs), targeting Photina ® to the mitochondria increased the signal strength as compared to the normal cytoplasmic expression of Photina. ® The mitochondrial-targeted Photina ® also produced a higher signal-to-noise ratio than conventional calcium dyes and a consistently stronger signal than aequorin when tested under equivalent conditions. MitoPhotina ® provided strong and reliable results when used to measure the activity of purinergic receptors endogenously expressed in the Chinese Hamster Ovary cells and heterologously expressed GPCRs in response to their cognate ligands. Several different types of flash luminescence plate readers (FLIPR 3 , FLIPR TETRA , CyBi ® -Lumax flash HT, Lumilux ® , Lumibox) in different plate formats (96, 384, 1536 wells) were used to validate the use of Photina ® in HTS. The cell number had to be adjusted to correspond to the qualities of the different readers, but once so adjusted, it provided equivalent results on each device. The results obtained show robust and reproducible light signals that offer new possibilities for application of photoproteins to the generation of cell-based assays for HTS. (Journal of Biomolecular Screening 2007:694-704) 
INTRODUCTION
T HE CENTRAL ROLE of Ca 2+ in intracellular signaling makes it a very attractive reporter for the process of drug discovery. 1 Many of the most interesting target classes for the pharmaceutical industry, such as G protein-coupled receptors (GPCRs), ion channels, and transporters, trigger a Ca 2+ mobilization upon activation. 2 Determination of the activity of targets by measurement of increased intracellular Ca 2+ concentration is now a very common approach, and the development of more sensitive and reliable technologies for the measurement of Ca 2+ concentration has long been a matter of interest.
The 1st Ca 2+ mobilization assays were developed using fluorescent probes that exhibit a rapid change in fluorescence intensity by complex formation with Ca 2+ and were mainly used for fluorescence microscopy, flow cytometry, and fluorescence spectroscopy. Their use for high-throughput screening (HTS) was limited until the development of the fluorometric imaging plate reader (FLIPR ® ), 3 an imaging instrument capable of simultaneously making measurements of up to 384 wells.
Although the use of fluorescent probes has become very common in HTS, their use is complicated by the inherent fluorescence of dye-loaded cells, which leads to a relatively low signal-to-noise ratio. In contrast, cells do not inherently emit visible light in the presence of heterologously expressed photoproteins, which leads to a relatively large signal-to-noise ratio. In addition, photoproteins allow Ca 2+ concentrations to be measured at specific cellular sites with appropriate targeting. [4] [5] [6] Both fluorescent and luminescent detection systems are subject to interference by compounds that quench or absorb light in an unspecific manner. Compounds that interfere with fluorescent detection systems are more common and harder to detect prior to testing than those that interfere with luminescent detection systems. 7 For these reasons, the use of Ca 2+ -activated photoproteins, with their inherent flash-type luminescence, represents a significant improvement of fluorescence-based Ca 2+ mobilization assays. [8] [9] [10] Many luminescent organisms are known, but only 7 photoproteins have been isolated from them so far, namely, thalassicolin, 11, 12 aequorin, [13] [14] [15] mitrocromin/halistaurin, 16, 17 clytin/phialidin, 17, 18 obelin, 11, 15, 19, 20 mnemiopsin, 21, 22 and berovin. 21, 22 The term photoprotein refers to a luciferin-bound polypeptide that is capable of luminescence, whereas apophotoprotein refers to a photoprotein without luciferin. Upon incubation with the luciferin coelenterazine and molecular oxygen, the apoproteins are reconstituted into their active forms. 23 The intensity of light emission caused by the activation of a photoprotein can vary depending on the type of coelenterazine used. 22 The binding of Ca 2+ ions to the 3 highly conserved Ca 2+ -binding sites (EF-hand structures) of the active complex induces a conformational change, resulting in the oxidation of coelenterazine to coelenteramide and the emission of photons in the blue range of the visible spectrum (λ max = 470 nm).
The most commonly studied photoproteins are aequorin, isolated from Aequorea victoria, 24 and obelin, 25 isolated from Obelia longissima. Aequorin assays have been validated for many GPCRs and some Ca 2+ channels, and the results obtained are comparable to those obtained with the use of fluorescent dyes. 26 The adaptation of aequorin assays to HTS, however, is not always easy. Aequorin has a low quantum yield, and the reaction kinetic is very fast.
Photoproteins able to emit a brighter signal for a longer period of time would represent a significant advance in improving the sensitivity and utility of photoproteins in HTS. For this reason, we have engineered a new Ca 2+ -activated photoprotein, which we have named Photina ® , which works similarly to aequorin but releases considerably more light. 27 The features of Photina ® and its application to HTS for GPCRs are described in this work.
MATERIALS AND METHODS

Reagents
Restriction enzymes were purchased from New England Biolabs and used according to the manufacturer's instructions. Platinum Pfx DNA polymerase, reagents for PCR, competent cells of Escherichia coli strains TOP10 and all cell culture reagents were purchased from GIBCO (Carlsbad, CA). Oligonucleotides were purchased from Primm (Milan, Italy). The rapid DNA ligation kit (cat. no. 1 635 379) was purchased from Roche Diagnostics AG (Basel, Switzerland).
Coelenterazine derivatives (cat. no. C-6777) were obtained from Molecular Probes (Carslbad, CA). Tyrode buffer was composed of 130 mM NaCl, 5 mM KCl, 2 mM CaCl 2 , 1 mM MgCl 2 , 5 mM NaHCO 3 , and 20 mM HEPES, pH 7.4. Coelenterazine (cat. no. 260350) was purchased from PJK GmbH (Kleinblittersdorf, Germany). IMETIT (cat. no. I-135) and clobenpropit (cat. no. C-209) were purchased from Sigma-Aldrich (St. Louis, MO), and fractalkine (cat. no. 300-31) was purchased from Peprotech, Inc. (Rocky Hill, NJ). IMETIT and clobenpropit were dissolved in H 2 O at a concentration of 10 mM and 1 mM, respectively. Fractalkine was dissolved in H 2 O at a concentration of 10 µM. All the solutions were stored at -20 °C until use. Adenosine triphosphate (ATP; cat. no. A-7699), purchased from Sigma-Aldrich, was dissolved in H 2 O at a concentration of 100 mM and stored in aliquots at -20 °C until use. Working solutions were freshly prepared in Tyrode buffer. Triton ® X-100 (cat. no. 648462) was purchased from Calbiochem (EMD Biosciences, Inc., San Diego, CA).
Both the FLIPR Calcium Assay Kit (cat. no. R8033) and the FLIPR Calcium 3 Assay Kit (cat. no. 8090) were purchased from Molecular Devices (Sunnyvale, CA).
Cloning of Photina ® ®
The complete coding sequence of obelin gene (Entrez acc. no. U07128) was obtained by assembling overlapping oligonucleotides with PCR. 28 The resulting obelin construct was cloned into the pCR ® -Blunt vector (Invitrogen) and used in subsequent steps of cloning of the chimeric construct Photina ® .
The obelin sequence contains restriction sites for Nde and MunI, located in the central portion of the protein between the first 2 EF-hands. Four oligonucleotides spanning the region of clytin (Entrez acc. no. L13247) from nucleotides 156 to 291 were synthesized and used to generate a Nde/MunI fragment, which was cloned into the Nde and MunI sites of the obelin sequence to generate the new chimeric photoprotein. The complete Photina ® coding sequence was then subcloned into the expression vector pcDNA3 (Invitrogen).
The targeting of Photina ® to the mitochondria was achieved by cloning the first 29 amino acids of the N-terminal leader sequence of human cytochrome c oxidase, subunit VIII 29 in frame with the N-terminus sequence of Photina ® .
Creation of Chinese Hamster Ovary (CHO) cell lines stably expressing Photina ® ®
CHO-K1 cells (CRL-9618; American Type Culture Collection, Bethesda, MD) were grown in DMEM/F12 with GlutaMAX ® (GIBCO, cat. no. 31331-028, Invitrogen), 10% fetal bovine serum (GIBCO, cat. no. 10270-106), 1% penicillin/streptomicyn (cat. no. 15140-122; Invitrogen), 25 mM HEPES buffer solution (GIBCO, cat. no. 15630-056), 1.0 mM sodium pyruvate (GIBCO, cat. no. 11360-039), and 1.5 g/L sodium bicarbonate (GIBCO, cat. no. 25080-060). Cells were split twice a week to a density of 3 × 10 5 cells/T75 flask and were used for experiments at about 70% confluence.
CHO-K1 cells, grown to 70% confluence, were transfected by electroporation using a GenePulser ® II (BioRad, Hercules, CA) set to 300 V and 950 µF with 10 µg of pcDNA3/MitoPhotina ® vector and 10 µg of pcDNA3/Photina ® vector to generate CHO cells stably expressing the mitochondrial and the cytoplasmic versions of Photina ® , respectively.
Positive clones stably expressing functional MitoPhotina ® and Photina ® were chosen both on the basis of the best response to ATP and on the basis of the highest total content of photoprotein. On the day of the experiment, cell plates were incubated with Tyrode buffer containing 10 µM coelenterazine for 4 h at 37 °C. ATP was then injected onto the plates, and the light release was immediately recorded using a Lumibox CCD camera-based luminescence detector designed and built by Bayer Technologies GmbH (Wuppertal, Germany). The integration time was set to 1 s, and the total recording time was 30 s. To obtain clonal cell lines, the clones giving the best response were further purified by 3 limiting dilutions.
Creation of CHO MitoPhotina ® ® cell lines expressing transfected receptors
MitoPhotina ® CHO cells grown to 70% confluence were transfected under the same conditions as described above with the following expression vectors: the human Histamine 3 receptor (Entrez Acc. No: 11255) or the human CX3CR1 receptor (Entrez Acc. No: 1524) together with the human Gα16 protein. After 10 days of 2 mg/ml G418 selection, stably transfected cells underwent 3 rounds of limiting dilution to obtain pure clones. Functional clones were selected by measuring the Photina ® light release evoked by treatment of transfected cells with the specific GPCR agonist. This was done by plating cells into white 96-well plates, incubating them 2 days later with 5 µM coelenterazine for 3 h at 37 °C, and, after adding the specific ligand, measuring the produced light with the Lumibox as above. The same conditions were used to measure the response of the final stable cell lines.
After coelenterazine loading of the cells, different concentrations of specific ligands were injected, and light emission recording was performed using the following instruments: 
Measurement of cell viability
Cell viability was measured with the CellTiter-Glo ® Luminescent Cell Viability Assay Kit (Promega, Madison, WI).
RESULTS
Generation of Photina ® ®
Obelin exhibits a different bioluminescence spectrum than aequorin, as well as a slightly slower kinetic, which allows measurement of its signal for a longer period of time. 30, 31 Unfortunately, its low level of light emission limits the sensitivity that can be achieved, which is a major drawback for application to HTS. We hypothesized that the signal strength could be improved and the desirable kinetics retained if we included key regions from a less well-studied photoprotein, clytin.
The coding sequences of both clytin and obelin were aligned, and the structure of the proteins was analyzed. We reasoned it would be best not to disrupt the 3 EF-hand structures and flanking helix regions from obelin ( Fig. 1A) . We identified the least conserved section of the genes that did not involve these structures, which corresponds to the obelin region between EF-hand I and EF-hand II (amino acid residues 50 to 94), which was substituted with the corresponding region from the clytin gene (residues 53 to 97).
This chimera had suitable luminescence intensity and duration but still suffered from poor expression in mammalian cells. To increase the expression of the chimeric protein in the cells, a Kozak sequence was introduced, and the codon usage was modified in regions with a very high (>80%) or with a very low (< 30%) guanosine cytosine content. This engineered protein ( Fig. 1B) is well expressed in mammalian cells and has been named Photina ® .
Generation and characterization of CHO cell lines stably expressing Photina ® ® and MitoPhotina ® ®
One of the most important advantages of Ca 2+ -activated photoproteins relative to Ca 2+ dyes is that photoproteins can be targeted to subcellular compartments using appropriate targeting sequences. Unmodified Photina ® is expressed predominantly in the cytoplasm. The localization of a Ca 2+ -activated photoprotein in the mitochondria has been observed to amplify the luminescent response triggered by the activation of GPCRs coupled to the Gαq/ PLC pathway. 32, 33 So in addition to creating a stable cell line expressing unmodified Photina ® , we also created a stable cell line, which we call MitoPhotina ® , which targets Photina ® to the inner lumen of the mitochondria by adding the targeting sequence of human cytochrome c oxidase, subunit VIII. 29, 34 As shown in Figure 2 , the application of ATP to CHO cells expressing MitoPhotina ® or Photina ® activates endogenous purinergic receptors. After a brief delay, a 10-s flash of light is observed, which allows the kinetics to be followed using automated luminescence readers. The signal observed from MitoPhotina ® CHO cells is approximately 10-fold higher than the one obtained by applying the same stimulus to CHO cells containing untagged Photina ® when measured under identical conditions. To demonstrate that this difference in response amplitude is not simply due to a difference in the expression level of the photoprotein, the same cells used to make the primary measurement were treated with a buffer containing 2% Triton ® X-100 to disrupt the cell membranes and discharge all the remaining coelenterazine-Photina ® complexes due to the influx of calcium from the surrounding medium. The data in Figure 2 (inset box) show that the total signal produced by each cell line on lysis is slightly higher from the Photina ® cell line, indicating that Photina ® was at least as well expressed as the MitoPhotina ® cell line. Based on these results, we conducted the following experiments using MitoPhotina ® , unless otherwise indicated.
To evaluate the performance of Photina ® , relative to the most commonly used photoproteins, a CHO cell line expressing aequorin targeted to the mitochondria in the same manner as MitoPhotina ® was created. Cells were plated at the same density (750 cells/well) and stimulated 24 h later with various concentrations of ATP.
To compare the results, unstimulated control cells were treated with lysis buffer to discharge the coelenterazine-photoprotein complexes contained in the cells. The total light released reflects the amount of photoprotein expressed and available for complex formation. The values obtained were used to correct the results of the corresponding ATP stimulated cells. Figure 3 shows that the signal of Photina ® cells is approximately 3-fold higher than the signal of cells expressing aequorin in the mitochondria.
To determine if the type of coelenterazine affects the signal intensity produced by MitoPhotina ® , CHO cells were incubated with native coelenterazine or 1 of 5 different commercially available coelenterazine derivatives. The cells were subsequently treated with 5 µM ATP and the light emission measured. As shown in Figure 4A , the amount of light release varies over a wide range and is dependent on the coelenterazine derivative used. The f and native coelenterazine gave the strongest signals, so the native coelenterazine was used for all subsequent experiments.
Having selected the best cofactor for Photina ® , we next examined the optimal concentration of native coelenterazine. Increasing amounts of coelenterazine, ranging from 0.25 µM up to 10 µM, were incubated with MitoPhotina ® CHO cells ( Fig. 4B) . Incubation of the cells with 5 µM coelenterazine resulted in an almost maximal signal, very close to the plateau. We chose this concentration for further experiments as the best compromise between a robust and reproducible signal and minimizing use of a relatively expensive reagent.
We next investigated the amount of time required for the apoPhotina ® -coelenterazine complex to form inside cells. MitoPhotina ® CHO cells were incubated with native coelenterazine for 1 to 6 h before stimulation with ATP and measurement of the luminescence. An equal volume of buffer containing 2% Triton ® X-100 was added to the same cells 5 min after addition of ATP as above. As measured by light release, a substantial quantity of active Photina ® was formed within the 1st hour of incubation, increased substantially by 3 h, and continued to accumulate slowly thereafter. We selected 3 h as the final incubation time for all the experiments shown as the earliest time giving near maximal signal strength (Fig. 5A, dark bars) . Interestingly, endogenous purinergic receptor activation apparently mobilizes only a portion of the available Photina ® complexes (Fig. 5A , light bars). We next treated cells with various concentrations of ATP to ensure that a full dose response could be observed (Fig.  5B, dark bars) . Subsequent treatment of the cells with the Triton ® X-100 lysis buffer triggered a 2nd light release from the remaining Photina ® complexes, which inversely correlated with the initial, receptor-mediated signal (Fig. 5B, light bars) .
Using the experimental conditions defined in the previous experiments, the MitoPhotina ® CHO clone was analyzed with respect to its ATP response. Cells were seeded at different cell densities, ranging from as few as 50 up to 1500 cells/well in 384well plates. The intensity of the light signal varied almost linearly with the number of cells up to 250 cells/well (Fig. 6A) . Higher cell densities produced smaller increases in signal intensity on a per cell basis, but produced higher overall signals.
We then repeated the experiment at a fixed cell density of 100 cells/well and varied the concentration of ATP used to stimulate the cells. As shown in Figure 6B , a strong signal could be detected at or above 0.5 µM ATP, and the intensity of the signal increased in response to a greater ATP concentration. Thus, Photina ® allows assays using as few as 100 cells/well.
Characterization of the MitoPhotina ® ® CHO cell line stably expressing recombinant GPCRs
To further evaluate the usefulness of Photina ® in the generation of screening assays for GPCRs, the MitoPhotina ® CHO reporter cell line was transfected with the CX3CR1 receptor. It is natively coupled to Gαi subunits of G proteins and, when activated by fractalkine, inhibits adenylate cyclase, leading to a decrease in the level of intracellular cyclic adenosine monophosphate. To switch the coupling of the CX3CR1 receptor from Gαi to Gαq to produce a measurable Ca 2+ influx, the human Gα16 protein was coexpressed in the same cell line. The Gα16 protein readily associates with almost all GPCRs, regardless of their usual preference for Gα subunits. A stable clonal cell line was generated and tested using 2 different luminescence readers, the Lumibox and the FLIPR TETRA .
Preliminary experiments determined that 500 cells/well provided sufficient signal intensity when the Lumibox was used to measure the luminescence. CX3CR1/MitoPhotina ® CHO cells exhibited a classic dose response when treated with various concentrations of fractalkine (Fig. 7A) .
The FLIPR TETRA is designed to measure fluorescence but can also double as a luminescence reader. However, its camera is not specifically optimized for luminescence detection, so many more cells must be employed to generate a sufficient signal. In preliminary experiments, we determined that a minimum of 2500 cells/well are required. As shown in Figure 7B , the greater the cell number, the better the results, and the EC 50 values determined with the FLIPR TETRA were very similar to the value determined with the Lumibox.
Similar experiments were conducted to determine the optimal cell-seeding density for 4 common luminescence readers. The Lumibox required a very low cell number with MitoPhotina ® , and the CyBi ® -Lumax flash HT provided robust results with a moderate cell number. Although the FLIPR 3 and FLIPR TETRA required a considerably greater number of cells to allow reliable measurement, the remarkable fact is that these nonspecialized devices can be used for this purpose at all. Next CX3CR1/MitoPhotina ® CHO cells were seeded at a density of 1000 cells/well in 1536-well plates and treated with fractalkine to activate the heterologously expressed receptor or ATP to activate the endogenous purinergic receptors 24 h after seeding. The signal was recorded using the Lumilux ® instrument from PerkinElmer (Fig. 8A) . We created another stable transfected CHO cell line containing the histamine 3 receptor to ensure that the results from the CX3CR1/MitoPhotina ® CHO cells were representative and not unique to this cell line. Figure 8B shows the results of an analogous experiment to the one shown in Figure 8A but using IMETIT, a specific histamine 3 receptor agonist, instead of fractalkine and measured with the Lumilux ® . The data obtained clearly show that Photina ® is able to release enough light in each case to produce reliable measurements and determine consistent EC 50 values, even in 1536-well plates.
Photina ® produces strong and reliable signals and compares favorably to aequorin, but how does it compare to calciumsensitive fluorescent dyes? To answer this question, we used the H3/MitoPhotina ® cell line we generated in the previous experiment. Plates seeded the previous day with 10,000 cells/well were incubated either with 10 µM native coelenterazine for the luminescence assay or with the Calcium or Calcium 3 dyes from Molecular Devices for the fluorescence assays. The cells were stimulated with different concentrations of IMETIT, and the resulting light was measured with the FLIPR TETRA . The resulting data were used to calculate the EC 50 values and the signal-tonoise ratios, which are shown in Figure 9 . The EC 50 values 
FIG. 5. (A)
Determination of optimal incubation time for coelenterazine. MitoPhotina ® Chinese Hamster Ovary (CHO) cells were seeded at a density of 500 cells/well in white 384-well microplates and tested 24 h after plating. Cells were loaded for 1 to 6 h at 37 °C with 5 µM coelenterazine in Tyrode buffer, stimulated with 10 mM adenosine triphosphate (ATP), and the resulting luminescence was measured (dark columns). After 5 min, the same cells were disrupted with an equal volume of a buffer containing 2% Triton ® X-100 to set the remaining coelenterazine complexes free, and the luminescence was recorded for a further 30 s (light columns). Data are presented as mean ± standard deviation (n = 4). (B) Evaluation of ATP dose-response curve and residual Photina ® activity in MitoPhotina ® CHO cells. MitoPhotina ® CHO cells were seeded at a density of 500 cells/well in white 384-well microplates and tested 24 h after plating. Cells were loaded for 3 h at 37 °C with 5 µM native coelenterazine in Tyrode buffer and stimulated with the indicated concentrations of ATP, and the resulting luminescence was measured (dark columns). After 5 min, the same cells were disrupted with an equal volume of a buffer containing 2% Triton ® X-100 to set the remaining coelenterazine complexes free, and the luminescence was recorded for a further 30 s (light columns). Data are presented as mean ± standard deviation (n = 4). remain constant, as expected. In terms of signal-to-noise ratios, the Calcium 3 kit (Molecular Devices) performed slightly better than the Calcium kit in fluorescence mode, but Photina ® showed dramatically improved signal-to-noise ratios an order of magnitude higher than those of either calcium dye kit. Using Photina ® , it was possible to generate a signal that was approximately 5-fold over the noise signal with only 0.5 nM IMETIT, whereas the signal produced by the same concentration of IMETIT when using either of the calcium dyes was less than 2-fold over the noise level. This suggests that weak agonists could be detected in screening campaigns using Photina ® that would remain undetected when using either of the calcium dyes.
Having demonstrated that Photina ® works well in assays for agonists, we next turned our attention to determining the usefulness of Photina ® in assays for antagonists. Antagonist assays tend to be more common in pharmacological screening and represent a greater challenge to the assay technology.
For this purpose, we again used the CHO cells, which stably express the histamine 3 receptor. We investigated the behavior of the H3/MitoPhotina ® CHO cell line in a ligand doseresponse experiment. Cells were stimulated with different concentrations of IMETIT and measured with the Lumibox (Fig. 10A) . The result is a classic dose-response curve with a calculated EC 50 value of 1.2 nM, which is close to the published value of 8.1 nM. 35 When the cells were treated with clobenpropit, an H3 receptor antagonist, for 10 min prior to administration of 100 nM IMETIT, a dose-dependent inhibition of the Photina ® signal was observed (Fig. 10B) . The calculated IC 50 of 1.8 nM corresponds very well to the previously published value of 1.03 nM. 35 Thus, both agonist and antagonist assays can be successfully run using Photina ® with as few as 500 cells/well when using a sufficiently sensitive reader. The measurement was performed with the CCD camera set to 10% sensitivity. (B) CX3CR1/ MitoPhotina ® CHO cells were seeded at the indicated densities and were used 24 h after plating. The cells were prepared and measured as above except that the FLIPR TETRA was used to carry out the measurement of the luminescence. Data are presented as mean ± standard deviation D (n = 4). To ensure that these results were not dependent on the high sensitivity of the Lumibox, the same experiments were repeated and measured using the FLIPR 3 . We increased the cell number to 5000 per well, in keeping with our earlier findings. Under these conditions, the results were similar to those using the Lumibox, with an EC 50 value of 3.1 nM for IMETIT alone (Fig. 10C) and an IC 50 value of 3.3 nM for clobenpropit used to antagonize IMETIT (Fig 10D) .
The EC 50 and IC 50 values for IMETIT and clobenpropit were determined using different cell densities with the Lumibox, FLIPR 3 , and CyBi ® -Lumax flash HT. The results are summarized in Table 1 . When insufficient cells were plated, the resulting signal was too weak to provide results reliable enough for EC 50 /IC 50 determination, whereas too many cells saturated the camera. Each reader has an optimal density range for any given assay, which overlaps to only a limited degree. Within the optimal range, the EC 50 and IC 50 values cluster around the expected value. Thus, Photina ® can be used for both agonist and antagonist assays with a range of systems of varying sensitivity, indicating that the results are not measurement platform dependent.
Robustness of Photina ® assays for HTS campaigns
DMSO is by far the most common solvent for chemical compounds used in screening. In most cases, the DMSO is diluted to a final concentration of about 1%, which can, in some cases, interfere with assay performance. To rule out the possibility that DMSO affects the signal produced by Photina ® , we applied various DMSO concentrations to MitoPhotina ® and Photina ® cells and measured the result. We tested the effect of 5 different concentrations of DMSO (0.25% to 1.5%) on the response to 2 µM ATP applied to the MitoPhotina ® CHO cell line. DMSO in this concentration range did not affect the signal produced by Photina ® when mixed with ATP and measured immediately, nor when the cells were treated with DMSO for 10 min prior to stimulation with ATP (data not shown). Thus, Photina ® is not subject to interference by DMSO when used at typical screening concentrations.
We also found that Photina ® can be stably expressed in cells over long periods of time. No decrease in signal intensity or cell viability could be detected after 9 months in cell culture.
We have demonstrated that Photina ® produces good results in individual experiments that would typically be employed in secondary screening or substance characterization. Use of any reporter in HTS presents additional challenges, in that not only does the signal need to be strong but it must also be highly reliable, with a high signal-to-noise ratio and a low standard deviation.
To address the suitability of Photina ® for this challenging application, we have calculated the Z′ factor, 36 which is a generally accepted objective standard for assay quality. For the experimental evaluation of Z′ factor, half of 352 wells of a 384well plate were treated with 2 µM ATP to produce a positive signal and the other half with Tyrode buffer as a negative control. An 8-point dose-response curve was run in quadruplicate in parallel to ensure that the concentration of agonist used produced a maximal signal. Figure 11 demonstrates that there is an excellent separation of the positive results from the negative controls, which can also be seen in the Z′ value of 0.615.
A similar experiment was performed using CX3CR1/ MitoPhotina ® CHO cells seeded in ten 384-well plates to determine the suitability of Photina ® for use with heterologously expressed receptors. The plates were laid out as before, but 2 nM fractalkine was used to induce the positive response. The results of mean integral relative light units, standard deviation, coefficient of variation, and Z′ factor are presented in Table 2 . The results demonstrate that very similar Z′ values were observed when using these cells compared to the previous experiment evaluating the response to endogenously expressed purinergic receptors. The calculated Z′ values fall into a narrow range between 0.64 and 0.73, indicating a high level of reproducibility, which is critical for use in HTS. The experiments were repeated on a less sensitive instrument than the FLIPR TETRA . The results obtained confirmed that Photina ® also can be used in HTS applications on instrumentation not specifically designed for flash luminescence detection.
Taken together, the results demonstrate that Photina ® is not subject to interference by the common solvent DMSO and that the high signal-to-background ratio, low standard deviation, and good Z′ factor make Photina ® well suited to HTS assays using heterologously expressed GPCRs.
DISCUSSION
We have engineered a new photoprotein, Photina ® , to overcome some of the drawbacks of aequorin and calcium dyes due to insufficient signal intensity or duration. It was engineered by exchanging a part of the obelin sequence with a corresponding region in clytin to combine the best properties of each photoprotein. We further modified the nucleotide sequence to optimize the protein expression in mammalian cells. When expressed in CHO cells, unmodified Photina ® is predominantly expressed in the cytoplasm. To improve the signal strength in response to GPCR signaling, we engineered MitoPhotina ® to target the molecule to the mitochondria of cells.
After creation of stable cell lines expressing both versions of Photina ® , we set out to optimize the assay conditions. The best results were obtained with MitoPhotina ® incubated with 5 to 10 µM native coelenterazine for 3 h. As demonstrated in Figure 5 , the response to the maximal activation of a GPCR requires only part of the total activated Photina ® complexes present in cells. This ensures that sufficient active Photina ® complexes are available within the cells to give accurate results, even at the highest levels of stimulation. If insufficient reserves of Photina ® had been available, the signal strength would be determined by availability of Photina ® , rather than the degree of receptor activation. This in turn would generate false plateaus when the results are plotted and would greatly hinder EC 50 or IC 50 determination. Thus, the fact that Photina ® still has ample reserves after a maximal stimulation with ATP indicates that it is not limiting.
We first demonstrated that MitoPhotina ® responds well to the relatively well-expressed purinergic receptors on CHO cells. Assaying other endogenously expressed GPCRs can be more challenging, so any improvement in signal intensity is likely to benefit HTS assays. Equally good results were observed when assaying heterologously expressed Gαi-coupled receptors in the presence of Gα16 to convert receptor activation into a calcium signal.
Photina ® gave good results on various measurement platforms and in various plate formats, including 1536 wells ( Figs. 7, 8,  and 10) . FLIPR instruments are not specifically designed to detect luminescence, and yet Photina ® gives off enough light that 1536-well HTS assays are feasible. The only disadvantage relative to using more sensitive instruments is that the number of cells seeded into the plates had to be increased. We have so far not succeed in designing 1536-well assays on the FLIPR using aequorin expressed in the mitochondria. The use of a purposebuilt luminescence reader such as the CyBi ® -Lumax flash HT or the Lumilux ® allowed use of as few as 100 to 500 cells per well. We found that Photina ® is suited for use in 1536-well format, with only minimal assay adaptation required. This could represent a significant advance that will allow use of this technology to become much more widespread.
For companies interested in screening very large libraries, the need for only a few hundred to a few thousand cells per well can significantly lower the amount of cell culture support required to conduct a screening campaign. This in turn can lead to significant gains in efficiency due to higher throughput, less labor, and lower costs. An average Z′ factor value of 0.7 for most of the tested assays and insensitivity to DMSO up to 1% also provide the required sensitivity and robustness for application to HTS. FIG. 11 . Mean, standard deviation, and Z′ factor evaluation under high-throughput screening conditions. MitoPhotina ® Chinese hamster ovary cells were seeded at 300 cells/well in 384-well plates 24 h prior to the experiments. Cells were loaded for 3 h at 37 °C with 5 µM coelenterazine in Tyrode buffer. Luminescence was monitored with Lumibox for 30 s after injection of 2 mM adenosine triphosphate to half of the wells. The mean, standard deviation, and Z′ factor of the results were calculated. cells/well and were tested 24 h later by injection of 2 nM fractalkine into half of the wells (control max) and Tyrode buffer into the other half (control min). Light release was recorded for 30 s using the Lumibox. The mean, standard deviation, coefficient of variation (CV) and Z′ factor were calculated for each individual plate in the experiment. (Bottom) CX3CR1/MitoPhotina ® CHO cells were seeded in four 384well plates at a density of 5000 cells/well and were tested 24 h later by injection of 2 nM fractalkine into half of the wells. Light release was recorded for 30 s using the FLIPR TETRA . The mean, standard deviation, CV, and Z′ factor were calculated for each individual plate in the experiment.
